Jul 24, 2015 by Brian FeroldiWhy Shares of Spectranetics Corp Crashed TodayDisappointing guidance for the rest of the year caused shares of Spectranetics to fall hard.
Jul 22, 2015 by Brian FeroldiAmgen Inc. Grabs a Potential Blockbuster ApprovalAmgen gains an approval in the European Union for its potential blockbuster cholesterol medication Repatha. Here's why it matters for Amgen investors.
Jul 22, 2015 by Brian FeroldiWhy Shares of Fibrocell Science Jumped TodayShares of clinical stage gene therapy company Fibrocell Science rose sharply today on details related to the company's secondary offering. Is the move meaningful, or just market noise?
Jul 22, 2015 by Brian Feroldi5 Reasons Celgene Corporation Is a BuyCelgene has been a monster stock for investors, and this Fool thinks the future continues to look bright. Here are five reasons Celgene is a buy today.
Jul 20, 2015 by Brian FeroldiThis Orphan Drugmaker Deserves a Spot on Your RadarOrphan drug maker BioMarin has been a terrific stock for long-term investors, but is its pipeline strong enough to continue to propel the stock higher?
Jul 19, 2015 by Brian FeroldiWhat's in bluebird bio's Pipeline That Has Investors So Excited?Bluebird bio has been a red-hot stock since its IPO in 2013. What's in its pipeline to justify the strong stock movement?
Jul 11, 2015 by Brian FeroldiWhy July Will Be an Exciting Month for Regeneron PharmaceuticalsRegeneron Pharmaceuticals will hear back from the FDA this month on an approval decision for one of its most promising drug candidates, and investors should be excited about the potential the drug holds.
Jul 8, 2015 by Brian Feroldi3 Stocks to Buy in a Market CrashMy shopping list if a market crash comes to pass.
Jul 7, 2015 by Brian FeroldiIs This Novo Nordisk's Next Blockbuster Drug?Novo recently presented terrific data on its pipeline drug IDegLira, but U.S. approval is still far from certain. If it can gain approval, will it be meaningful to the company?
Jul 7, 2015 by Brian FeroldiGilead Sciences Gets Another Green Light in JapanGilead Sciences' Hepatitis C drug Harvoni gets approval for sale in Japan. Will that be meaningful to the company's future?
Jul 7, 2015 by Brian FeroldiWill Healthcare Providers Push Back Against a More Connected World?Medical devices are getting smarter and more connected than ever, which is great for patients who wear them. But how will providers react to these new innovations?
Jul 6, 2015 by Brian FeroldiCan Celgene Corporation's Superior Earnings Growth Continue?Celgene has grown earnings far faster than revenue over the past several years. Can they keep it up, or are margins set to peak?
Jun 30, 2015 by Brian FeroldiInsiders Love These 3 Biotech StocksThese three biotech stocks have big inside ownership, which means their management has a lot of financial incentive to make the company succeed.
Jun 30, 2015 by Brian FeroldiCelgene Corporation's $4 Billion Bet That Its Stock Is CheapBiotech giant Celgene Corp. has announced another huge stock buyback program. Will it move the needle for investors?
Jun 28, 2015 by Brian FeroldiWhy Samsung Is Partnering Up with This Healthcare CompanySamsung is following Apple into the wearables market by partnering with this healthcare giant. Will the partnership move the needle for either company?
Jun 27, 2015 by Brian FeroldiWall Street is Betting Big Against These 3 BiotechsBiotech stocks have had a huge run recently, and now Wall Street is betting heavily against these 3 recent winners.
Jun 27, 2015 by Brian FeroldiIsis Pharmaceuticals Inc. Investors Can Finally Sense a Bright FutureAfter decades of zero return, Isis Pharmaceuticals' stock has been on fire recently. Is it smart to jump on board now?
Jun 25, 2015 by Brian FeroldiThe Revenue Challenge Ahead for Eli Lilly and CoEli Lilly has lost patent protection in recent years for several blockbuster drugs, with more losses on the way. Here are the details investors need to know.
Jun 18, 2015 by Brian FeroldiWhy Radius Health Inc Stock Skyrocketed TodayShares of pharmaceutical company Radius Health soared today after posting great clinical outcome news.
Jun 18, 2015 by Brian FeroldiBetter Buy: Gilead Sciences Inc. or Celgene Corporation?Celgene and Gilead have been great stocks to own over the past few years. Which one is a better buy at today's prices?
